Zimmer Biomet Holdings Inc - Asset Resilience Ratio
Zimmer Biomet Holdings Inc (ZBH) has an Asset Resilience Ratio of 6.24% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Zimmer Biomet Holdings Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2024)
This chart shows how Zimmer Biomet Holdings Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Zimmer Biomet Holdings Inc to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Zimmer Biomet Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zimmer Biomet Holdings Inc (ZBH) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.38 Billion | 6.24% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.38 Billion | 6.24% |
Asset Resilience Insights
- Limited Liquidity: Zimmer Biomet Holdings Inc maintains only 6.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Zimmer Biomet Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Zimmer Biomet Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Zimmer Biomet Holdings Inc (2003–2024)
The table below shows the annual Asset Resilience Ratio data for Zimmer Biomet Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.46% | $525.50 Million | $21.37 Billion | +0.40pp |
| 2023-12-31 | 2.06% | $442.00 Million | $21.50 Billion | +0.24pp |
| 2022-12-31 | 1.82% | $382.50 Million | $21.07 Billion | -0.29pp |
| 2021-12-31 | 2.11% | $494.80 Million | $23.46 Billion | -1.18pp |
| 2020-12-31 | 3.28% | $802.10 Million | $24.42 Billion | +0.78pp |
| 2019-12-31 | 2.51% | $617.90 Million | $24.64 Billion | +0.26pp |
| 2018-12-31 | 2.25% | $542.80 Million | $24.13 Billion | +0.23pp |
| 2017-12-31 | 2.02% | $524.40 Million | $26.01 Billion | -0.36pp |
| 2016-12-31 | 2.38% | $634.10 Million | $26.68 Billion | +1.78pp |
| 2015-12-31 | 0.60% | $164.60 Million | $27.41 Billion | -5.76pp |
| 2014-12-31 | 6.36% | $612.50 Million | $9.63 Billion | -1.23pp |
| 2013-12-31 | 7.59% | $727.00 Million | $9.58 Billion | +0.14pp |
| 2012-12-31 | 7.45% | $671.60 Million | $9.01 Billion | +2.10pp |
| 2011-12-31 | 5.35% | $455.50 Million | $8.52 Billion | +2.04pp |
| 2010-12-31 | 3.31% | $265.10 Million | $8.00 Billion | +2.46pp |
| 2009-12-31 | 0.85% | $66.40 Million | $7.79 Billion | +0.82pp |
| 2008-12-31 | 0.04% | $2.70 Million | $7.24 Billion | 0.00pp |
| 2007-12-31 | 0.04% | $2.50 Million | $6.63 Billion | 0.00pp |
| 2006-12-31 | 0.04% | $2.40 Million | $5.97 Billion | -0.17pp |
| 2005-12-31 | 0.21% | $12.10 Million | $5.72 Billion | -0.12pp |
| 2004-12-31 | 0.33% | $18.90 Million | $5.70 Billion | +0.05pp |
| 2003-12-31 | 0.28% | $14.50 Million | $5.16 Billion | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more